From DCAT Value Chain Insights (VCI)
Mylan N.V. has appointed Anthony (Tony) Mauro to chief commercial officer.
In his new role, which reports to Mylan President Rajiv Malik, Mr. Mauro will now be responsible for overseeing global sales excellence and operations of all commercial markets around the world. Until his successor is appointed, Mauro will continue his current role as president of North America.
Mr. Mauro has been with Mylan for more than 20 years and has successfully led its largest commercial business–the North American region–for the last four of them. He has served the company in several capacities of increasing responsibility, including president of Mylan Pharmaceuticals Inc., the company's flagship generics division in the US; chief operating officer of Mylan Pharmaceuticals ULC in Canada; vice president of North America Strategic Development; and vice president of North America Sales. Mauro also served as chairman of the board of directors for the US Generic Pharmaceutical Association (GPhA) for two consecutive terms in 2012 and 2013, and prior to that served two consecutive terms as vice chairman of the board for GPhA.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription